Sphera Funds Management Ltd. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $638 Million distributed in 105 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $26.7M, Sanofi with a value of $24.3M, Nice Ltd. with a value of $22.4M, Cytokinetics Inc with a value of $19.7M, and Syndax Pharmaceuticals Inc with a value of $19.3M.

Examining the 13F form we can see an increase of $48.2M in the current position value, from $590M to 638M.

Sphera Funds Management Ltd. is based out at Tel Aviv, L3

Below you can find more details about Sphera Funds Management Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $638 Million
Healthcare: $445 Million
Technology: $113 Million
ETFs: $36.1 Million
Communication Services: $17.6 Million
Consumer Cyclical: $17.4 Million
Basic Materials: $2.64 Million
Industrials: $1.43 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 105
  • Current Value $638 Million
  • Prior Value $590 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 23 stocks
  • Additional Purchases 23 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 31 stocks
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.